1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NHLBI-AI Enabled Precision Medicine Initiative for Heart, Lung, Blood, and Sleep (HLBS) Health is sponsored by National Heart, Lung, and Blood Institute (NHLBI) (part of NIH). This initiative aims to accelerate the use of AI in precision medicine for heart, lung, blood, and sleep health.
It supports research that develops and applies AI-enabled approaches to advance our understanding, prevention, diagnosis, and treatment of HLBS diseases.
Get alerted about grants like this
Get emailed when new opportunities from “National Heart, Lung, and Blood Institute (NHLBI) (part of NIH)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Small Businesses; For-Profit Organizations (Other than Small Businesses). Confirm the full requirements in the official notice before applying.
NHLBI-AI Enabled Precision Medicine Initiative for Heart, Lung, Blood, and Sleep (HLBS) Health is funded by National Heart, Lung, and Blood Institute (NHLBI) (part of NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward interdisciplinary projects that leverage AI, machine learning, and advanced data science to address pressing questions in biomedical and public health research. It seeks to advance fundamental scientific and engineering contributions across disciplines to solve key health problems.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleThe April 14 SBIR/STTR reauthorization restarted NIH's small-business pipeline after the shutdown, but the real signal is the sequencing of the new Small Business 101 webinars: program overview June 9, budget July 14, foreign risk August 18.
Read articleThe NIH awarded 5,564 fewer grants in FY2025 than the year before, and FY2026 looks worse. A deep analysis of forward funding, politicization, leadership gaps, and what researchers should do now.
Read article